McKesson Corp (MCK) stock

MCKNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31

Financials through Q2 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3026% above fair value

$1102.81+25.76 (+2.39%)

Close on Nov 13, 2026Market cap $128.58BP/E 28.4Yield 0.29%

McKesson EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

McKesson's EV/EBITDA was 20.1× on Nov 11, 2026, against 20.7× a year earlier. Over the last 5 years it ranged from 13.0× to 27.0×, with a median of 19.6×.

EV/EBITDA at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	20.1×	+0.8
2025	Dec 31, 2025	19.3×	−3.3
2024	Dec 31, 2024	22.6×	+6.9
2023	Dec 29, 2023	15.7×	−3.3
2022	Dec 30, 2022	19.0×	+5.4
2021	Jan 29, 2021	13.6×	+0.0
2020	Dec 31, 2020	13.5×	−6.3
2019	Dec 31, 2019	19.8×	+1.6
2018	Dec 31, 2018	18.3×	+12.9
2017	Dec 29, 2017	5.4×	−3.2
2016	Dec 30, 2016	8.5×	−3.2
2015	Dec 31, 2015	11.7×	−6.2
2014	Dec 31, 2014	17.9×	+4.0
2013	Dec 31, 2013	13.8×	+4.3
2012	Dec 31, 2012	9.6×	+1.3
2011	Dec 30, 2011	8.3×	+0.9
2010	Dec 31, 2010	7.4×	−2.3
2009	Dec 31, 2009	9.7×	–